ARTICLE | Financial News
V-Bio closes EUR 76M fund
December 2, 2016 12:30 AM UTC
V-Bio Ventures closed its first life sciences fund at EUR 76 million ($81 million). LPs include the European Investment Fund (EIF), PMV-ARKimedes, Korys, KU Leuven, Gimv, SFPI-FPIM, BNP Paribas Fortis Private Equity and Ghent University.
V-Bio Ventures Fund 1 is designed to fund 15-18 early stage companies developing therapeutics, diagnostics and agricultural products. ...
BCIQ Company Profiles